Which of the following best describes a disease that should be reported to the local or regional public health department? A. Diseases where public health intervention is needed to help prevent spread to the region or community. B. Diseases with significant rates of mortality and morbidity. C. Diseases that are most often noted among individuals with significant immunocompromise. D. Diseases where intervention in early life helps lead to improved health in adulthood...
All content for NP Certification Q&A is the property of Fitzgerald Health Education Associates and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Which of the following best describes a disease that should be reported to the local or regional public health department? A. Diseases where public health intervention is needed to help prevent spread to the region or community. B. Diseases with significant rates of mortality and morbidity. C. Diseases that are most often noted among individuals with significant immunocompromise. D. Diseases where intervention in early life helps lead to improved health in adulthood...
Mrs. Mahem is a 68-year-old patient with a 25-year history of type 2 diabetes mellitus. In the past year, her A1c remains at around 8.5% with the use of the following medications: metformin, sitagliptin, and canagliflozin, at optimized doses and with adherence. She states, “ I haven’t changed the way I eat and I walk about ½ h a day, just like I have for years”. Additional health issues include HTN and dyslipidemia, treated with medications and at therapeutic goal, and obesity with a BM...
NP Certification Q&A
Which of the following best describes a disease that should be reported to the local or regional public health department? A. Diseases where public health intervention is needed to help prevent spread to the region or community. B. Diseases with significant rates of mortality and morbidity. C. Diseases that are most often noted among individuals with significant immunocompromise. D. Diseases where intervention in early life helps lead to improved health in adulthood...
